Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376695 · ClinicalTrials.gov registry record · NA
Radicle GI Health 24: A Study of Health and Wellness Products on GI Health and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 4,607
- Enrollment target
NCT06376695: Completed NA study, sponsored by Radicle Science.
NCT06376695 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 4,607 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (228% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06376695, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,607 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes
Primary Outcome
Mean difference in Gastrointestinal Health scores as assessed by Patient Reported Outcome Measurement System (PROMIS) Gastrointestinal Belly Pain 5A (scale 2-25; with higher scores corresponding to more severe abdominal pain)
Interventions
- DIETARY_SUPPLEMENT Radicle GI Health Placebo Control Form 1
- DIETARY_SUPPLEMENT Radicle GI Health Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Radicle GI Health Placebo Control Form 2
- DIETARY_SUPPLEMENT Radicle GI Health Active Study Product 2.1 Usage
- DIETARY_SUPPLEMENT Radicle GI Health Placebo Control Form 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,607 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2025-06-05 |
| Phase | NA |
What the finished NCT06376695 record still lists
NCT06376695 is an interventional study that assigns participants to a tested intervention. Its 4,607 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (228% higher).
The record links to 0 conditions, and to 5 interventions - of which Radicle GI Health Placebo Control Form 1 is the first listed.
NCT06376695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06376695 about?
NCT06376695 is a clinical study titled "Radicle GI Health 24: A Study of Health and Wellness Products on GI Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes
What is the current status of trial NCT06376695?
This trial is currently completed. It is a NA study. The enrollment target is 4,607 participants. The study started on 2024-04-29. Estimated completion is 2025-06-05.
What interventions are being tested in trial NCT06376695?
The interventions under investigation include: Radicle GI Health Placebo Control Form 1 (DIETARY_SUPPLEMENT), Radicle GI Health Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Radicle GI Health Placebo Control Form 2 (DIETARY_SUPPLEMENT), Radicle GI Health Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT), Radicle GI Health Placebo Control Form 3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06376695?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06376695's enrollment target sits among peer trials
4,607 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI